S.2134 - Act to Ban Zohydro

A bill to withdraw approval for the drug Zohydro ER and prohibit the Food and Drug Administration from approving such drug unless it is reformulated to prevent abuse. view all titles (2)

All Bill Titles

  • Short: Act to Ban Zohydro as introduced.
  • Official: A bill to withdraw approval for the drug Zohydro ER and prohibit the Food and Drug Administration from approving such drug unless it is reformulated to prevent abuse. as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 2
  • Past Seven Days: 5
  • All-Time: 255
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
03/13/14
 
 
 
 
 
 
 

Official Summary

Act to Ban Zohydro - Ends the sale and distribution of pure hydrocodone bitartrate extended-release capsules (marketed as Zohydro ER) within 45 days by withdrawing approval for its new drug application. Prohibits the Commissioner of Food and Drugs (FDA) from approving any new drug applicati

Official Summary

Act to Ban Zohydro - Ends the sale and distribution of pure hydrocodone bitartrate extended-release capsules (marketed as Zohydro ER) within 45 days by withdrawing approval for its new drug application. Prohibits the Commissioner of Food and Drugs (FDA) from approving any new drug application for the capsules unless they are formulated to prevent abuse.

...Read the Rest


Latest Letters to Congress

See All Letters (23)
 


Vote on This Bill

33% Users Support Bill

3 in favor / 6 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC